Elaboration and "in vitro" characterization of 5-ASA beads

Drug Development and Industrial Pharmacy

Volumn 31, Issue 2, 2005, Pages 231-239

  Iruin A ^a   Fernandez Arevalo M ^a   Alvarez Fuentes J ^a   Fini, A ^b   Holgado, M A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

5 ASA; Alginate beads; Chitosan; Eudragit FS 30D; Eudragit S100; Ulcerative colitis

Indexed keywords

ACRYLIC ACID METHYL ESTER; ALGINIC ACID; CHITOSAN; EUDRAGIT; MESALAZINE; METHACRYLIC ACID; METHACRYLIC ACID METHYL ESTER; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG FORMULATION; DRUG MECHANISM; DRUG RESEARCH; GELATION; IN VITRO STUDY; MEDICAL ASSESSMENT; PH; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ALGINATES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOCOMPATIBLE MATERIALS; CALIBRATION; COLON; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MESALAMINE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; SOLUBILITY;

EID: 14644422239     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-200047813     Document Type: Article

References (21)

1. Clarke, G. M., Newton, J. M., & Short, M. D. (1993). Gastrointestinal transit of pellets of differing size and density. International Journal of Pharmaceutics, 10:81-92.
2. Coupe, A. J., Davis, S. S., & Wilding, I. R. (1991). Variation in gastrointestinal transit of pharmaceutical dosage form in healthy subject. Pharmaceutical Research, 8:360-364.
3. Fernández-Hervás, M. J., Holgado, M. A., Fini, A., & Fell, J. T. (1998). In vitro evaluation of alginate beads of a diclofenac salt. International Journal of Pharmaceutics, 163:23-34.
4. Filipovic-Grcic, J., Becirevic-Lacan, M., Skalko, N., & Jalsenjak, I. (1996). Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. International Journal of Pharmaceutics, 135:183-190.
5. Folkier, N., & Doelker, E. (1980). Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage form. STP Pharma Sciences, 2:141-158.
6. French, D. L., & Mauger, J. W. (1993). Evaluation of the physicochemical properties and dissolution, characteristics of mesalamine: relevance to controlled intestinal drug delivery. Pharmaceutical Research, 10:1285-1290.
7. Hogan, J. E., & Auton, A., (Eds.). (1995). Pharmaceutical Coating Technology. London: Taylor and Francis, pp. 409-438.
8. http://www.el-mundo.es/anuncios/GrupoSB/noticias/1999/octubre/intestinal. html.
9. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1993). Mechanism of solute release from porous hydrophilic polymers. International Journal Pharmaceutics, 15:25-35.
10. Lamprecht, A., Roder, H., Schäfer, U., & Lehr, C. M. (2000). Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease. Journal of Controlled Release, 69:445-454.
11. Li, X. (1996). The use of chitosan to increase the stability of calcium alginate beads with entrapped yeast cells. Biotechnology and Applied Biochemistry, 23:269-271.
12. Lin, J. H., & Liaw, S. J. (1997). On the assessment of similarity of drug dissolution profiles - a simulation study. Drug Information Journal, 31:1273-1289.
13. Lin, L., Lin, S., Ng, S., Froix, M., Ohmo, T., & Heller, J. (1997). Controlled release of interleukin-2 for tumour inmunotherapy using alginate/chitosan porous microspheres. Journal of Controlled Release, 43:65-74.
14. Mi, F., Her, N., Kuan, C., Wong, T., & Shyu, S. (1997). Chitosan tablets for controlled release of theophylline: effect of polymer-drug wet or dry blending and anionic-cationic interpolymer complex. Journal of Applied Polymer Sciences, 66:2495-2505.
15. Moore, J. W., & Flanner, H. H. (1996). Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharmaceutical Technology, 20:64-74.
16. Polk, A., Ansden, B., De Yao, K., Peng, T., & Goosen, M. F. A. (1997). Controlled release of albumin from chitosan-alginate microcapsules. Journal of Pharmaceutical Sciences, 83:178-185.
17. Rudolph, M. W., Klein, S., Beckert, T. E., Petereit, H. U., & Dressman, J. B. (2001). A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. European Journal of Pharmaceutics and Biopharmaceutics, 51:183-190.
18. Tapia, C., Costa, E., Moris, M., Sapag-Hagar, J., Valenzuela, F., & Basualto, C. (2002). Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate. Drug Development and Industrial Pharmacy, 28:217-224.
19. Turkoglu, M., & Ugurlu, T. (2002). In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. European Journal of Pharmaceutics and Biopharmaceutics, 53:65-73.
20. (2003). USP 26 - NF 21 U.S. Pharmacopeia and National Formulary.
21. Wiwattanapatapee, R., Lomlim, L., & Saramunee, K. (2003). Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid. Journal of Controlled Release, 88:1-9.